Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Albengres

Showing results (21-30 of 85) with videos related to

Pageof 9
Sort By:
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1985
Present and future trends in drug monitoringJ P Tillement, E Albengres, P Riani, et al.
Annales De Biologie Clinique|January 1, 1986
[Rational posology and drug dosage]P Riant, E Albengres, J Barre, et al.
Therapie|September 1, 1983
[Tolerability of human leukocyte interferon in children. Evaluation of a series of 11 cases]C Meistelman, E Albengres, P Reinert, et al.
European Journal of Rheumatology and Inflammation|January 1, 1982
Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compoundsE Albengres, S Urien, J Kusmierek, et al.
La Nouvelle Presse Medicale|October 30, 1980
[Hypolipidaemic agents (author's transl)]J P Tillement, E Albengres, H Choisy, et al.
Biochemical Pharmacology|November 15, 1982
Evidence for binding of certain acidic drugs to alpha 1-acid glycoproteinS Urien, E Albengres, R Zini, et al.
Annales Pharmaceutiques Francaises|August 1, 2000
[Interactions and incompatibilities in prescription drugs. Incidents in dental surgery]J P Tillement, C Hannaire, M Grandidier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1988
Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studiesJ Barre, S Urien, E Albengres, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarinS Urien, E Albengres, J L Pinquier, et al.
Therapie|September 1, 1993
[Thrombopenia caused by isoniazid]C Guy, C Broyet, E Albengres, et al.
Pageof 9

Showing results (21-30 of 85) with videos related to

Sort By:
Pageof 9
International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1985
Present and future trends in drug monitoringJ P Tillement, E Albengres, P Riani, et al.
Annales De Biologie Clinique|January 1, 1986
[Rational posology and drug dosage]P Riant, E Albengres, J Barre, et al.
Therapie|September 1, 1983
[Tolerability of human leukocyte interferon in children. Evaluation of a series of 11 cases]C Meistelman, E Albengres, P Reinert, et al.
European Journal of Rheumatology and Inflammation|January 1, 1982
Benoxaprofen: plasma binding and binding interactions with some drugs and endogenous compoundsE Albengres, S Urien, J Kusmierek, et al.
La Nouvelle Presse Medicale|October 30, 1980
[Hypolipidaemic agents (author's transl)]J P Tillement, E Albengres, H Choisy, et al.
Biochemical Pharmacology|November 15, 1982
Evidence for binding of certain acidic drugs to alpha 1-acid glycoproteinS Urien, E Albengres, R Zini, et al.
Annales Pharmaceutiques Francaises|August 1, 2000
[Interactions and incompatibilities in prescription drugs. Incidents in dental surgery]J P Tillement, C Hannaire, M Grandidier, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|January 1, 1988
Plasma and tissue binding as determinants of drug body distribution. Possible applications to toxicological studiesJ Barre, S Urien, E Albengres, et al.
Clinical Pharmacology and Therapeutics|June 1, 1986
Role of alpha-1 acid glycoprotein, albumin, and nonesterified fatty acids in serum binding of apazone and warfarinS Urien, E Albengres, J L Pinquier, et al.
Therapie|September 1, 1993
[Thrombopenia caused by isoniazid]C Guy, C Broyet, E Albengres, et al.
Pageof 9